Page last updated: 2024-09-04

cyc 202 and Retinoblastoma

cyc 202 has been researched along with Retinoblastoma in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Lasowski, F; Sheardown, H	1
Sage, J	1

Other Studies

2 other study(ies) available for cyc 202 and Retinoblastoma

Article	Year
Atropine and Roscovitine Release from Model Silicone Hydrogels. Optometry and vision science : official publication of the American Academy of Optometry, 2016, Volume: 93, Issue:4 Topics: Antineoplastic Agents; Atropine; Contact Lenses, Hydrophilic; Drug Delivery Systems; Feasibility Studies; Humans; Hydrogels; Mydriatics; Myopia; Purines; Retinal Neoplasms; Retinoblastoma; Roscovitine; Silicones; Water	2016
Hope in sight for retinoblastoma. Nature medicine, 2007, Volume: 13, Issue:1 Topics: Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase 6; Genetic Therapy; Humans; Models, Biological; Mutation; Protein Kinase Inhibitors; Purines; Retinoblastoma; Retinoblastoma Protein; Roscovitine; Signal Transduction	2007

Article

Year

Atropine and Roscovitine Release from Model Silicone Hydrogels.

Optometry and vision science : official publication of the American Academy of Optometry, 2016, Volume: 93, Issue:4

Topics: Antineoplastic Agents; Atropine; Contact Lenses, Hydrophilic; Drug Delivery Systems; Feasibility Studies; Humans; Hydrogels; Mydriatics; Myopia; Purines; Retinal Neoplasms; Retinoblastoma; Roscovitine; Silicones; Water

2016

Hope in sight for retinoblastoma.

Nature medicine, 2007, Volume: 13, Issue:1

Topics: Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase 6; Genetic Therapy; Humans; Models, Biological; Mutation; Protein Kinase Inhibitors; Purines; Retinoblastoma; Retinoblastoma Protein; Roscovitine; Signal Transduction

2007